Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Sept 2026 for Precision Biosciences INC, €5,269.
Filing timeline
BuySaleStanley Frankel
Insider track record
Disclosed buys
3
Disclosed sells
0
Signal history
Closed purchases
Market purchases
3
Positive at T+90
50%
Median T+90
+18.4%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +55.5%Entry US$4.52 · Close at T+90 US$7.03
- -18.7%Entry US$5.44 · Close at T+90 US$4.42
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stanley Frankel: trading record in brief
Stanley Frankel is a declared insider of Precision Biosciences Inc, with filings sourced from SEC (Form 4). We count 5 filings; the first trade dates from 4 May 2024 and the latest from 28 September 2026.
Every open-market trade on record is a purchase: 3 purchases worth €28k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 option exercises. In 2026 alone, the filings show 1 purchase and no sales.
Half of the purchases are above €11k and half below. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 30 September 2026, the filings show an open-market purchase worth €5,269 in Precision Biosciences Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Stanley Frankel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
1,000 shares@ US$6.00Common StockSEC:0001628280-26-063980:0
Canonical exit: 27 Dec 2026 (T+90)
2,700 shares@ US$4.7048.4% of flowCommon StockSEC:0001628280-25-057483:0
Canonical exit: 16 Mar 2026 (T+90)
2,700 shares@ US$4.9751.6% of flowCommon StockSEC:0001628280-25-043156:0
Canonical exit: 25 Dec 2025 (T+90)
9,826 sharesCommon StockSEC:0000950170-25-081726:0
4,202 sharesCommon StockSEC:0000950170-24-054579:0
5 of 5 declarations
